As India remains the thalassemia capital of the world, the Thalassemia Patients Advocacy Group (TPAG) has written an open ...

Tharu tribals face higher rates of thalassemia (22-24%) and sickle cell anaemia (60%) than the general population, prompting a medical camp for 2 lakh people.

Certain genotypes of α-thalassemia present with microcytosis ... of an RBC to be dyed by a variety of laboratory stains Red Blood Cell Indices Series of relationships characterizing erythrocytes ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

The patients belonging to not only from erstwhile Adilabad, Warangal, Karimnagar districts, but also from Sironcha of ...

VIJAYAWADA: Sickle cell anaemia and thalassemia remain major health concerns in the State, particularly among tribal ...

According to research studies and demographic surveys by the Union Ministry of Tribal Affairs and genetic researchers, sickle cell disease is widespread in many tribal groups of India, especially amon ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...